Here’s what you should know:
1. The attorney generals filed their initial suit in 2016 against several large pharmaceutical companies including Mylan and Teva Pharmaceuticals.
2. The attorney generals are requesting their suit be amended to include at least a dozen new companies.
3. The 12 possible new defendants are: Actavis Holdco; Actavis Pharma; Ascend Laboratories; Apotex Corp.; Dr. Reddy’s Laboratories; Emcure Pharmaceuticals; Glenmark Pharmaceuticals; Lannett Company; Par Pharmaceutical Companies; Sandoz; Sun Pharmaceuticals and Zydus Pharmaceuticals.
4. CNBC reports the companies colluded to raise prices.
5. The states are seeking injunctive relief, civil penalties and disgorgement of profits.
6. Connecticut Attorney General George Jepsen is leading the state coalition.
More articles on coding, billing and collections:
Why revenue cycle needs millennials — and, like, now
Creating a competitive edge at your facility: The patient experience
3 key thoughts on bundles and the ASC space
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.